Several of the treatments employed in this study, such as L. monocytogenes or E. coli infections and genetic activation of the Toll pathway in the fat body, have been shown to interfere with the insulin signalling pathway and subsequently decrease nutrient storage or growth [27,38,48]. This evidence concerns the gene INS and escherichia coli infection.